Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

WATSON LABS

  • FDA Approval
  • March 18, 2025, 08:50 UTC
  • 87
  • 0 comments

FDA approve TETRACYCLINE HYDROCHLORIDE

Comment Full text

MANKIND PHARMA

  • FDA Approval
  • March 18, 2025, 08:50 UTC
  • 91
  • 0 comments

FDA approve BIMATOPROST

Comment Full text

ZYDUS

  • FDA Approval
  • March 18, 2025, 08:50 UTC
  • 81
  • 0 comments

FDA approve APALUTAMIDE

Comment Full text

VKT PHARMA

  • FDA Approval
  • March 18, 2025, 08:50 UTC
  • 91
  • 0 comments

FDA approve SUMATRIPTAN SUCCINATE

Comment Full text

WATSON LABS

  • FDA Approval
  • March 18, 2025, 08:50 UTC
  • 94
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • March 18, 2025, 08:50 UTC
  • 76
  • 0 comments

FDA approve VALACYCLOVIR HYDROCHLORIDE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • March 18, 2025, 08:50 UTC
  • 76
  • 0 comments

FDA approve LANTHANUM CARBONATE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • March 18, 2025, 04:08 UTC
  • 80
  • 0 comments

FDA approve METFORMIN HYDROCHLORIDE

Comment Full text

KNIGHT THERAPS

  • FDA Approval
  • March 17, 2025, 17:59 UTC
  • 81
  • 0 comments

FDA approve MILTEFOSINE

Comment Full text

MSN

  • FDA Approval
  • March 17, 2025, 08:43 UTC
  • 67
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text
  • Previous
  • 218
  • 219
  • 220
  • 221
  • 222
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274040)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158497)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin